<!DOCTYPE html>
<html lang="en-gb">
<head>
  
  <meta charset="utf-8" />
  <meta content="IE=edge,chrome=1" name="X-UA-Compatible" />
  <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport" />
  
  <!-- meta tags -->
  <meta content="NICE" name="DC.Publisher" />
  <meta content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." name="DC.Rights.Copyright" />
  <meta content="eng" name="DC.Language" scheme="DCTERMS.ISO639-2T" />
  <meta content="Health, well-being and care" name="DC.Subject" scheme="eGMS.IPSV" />
  <meta content="Double-A" name="eGMS.accessibility" scheme="eGMS.WCAG10" />
  <meta content="2014-08-05" name="DC.Issued" scheme="DCTERMS.W3CDTF" />
  <meta content="2014-08-05" name="DC.Modified" scheme="DCTERMS.W3CDTF" />
  <meta content="CorporatePage" name="DC.Type" scheme="NICE.Publication.Types" />
  
  <meta content="BNF: British National Formulary - NICE" name="DC.Title" />
  
  <title>HYDROCORTISONE | Drug | BNF content published by NICE</title>
  <meta name="description" content="Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for HYDROCORTISONE."/>
  <meta name="author" content="NICE - The National Institute for Health and Care Excellence" />

  	<link rel="alternate" type="application/json" href="/drug/hydrocortisone.json" title="RDF/JSON version of this document"/>
  	<link rel="alternate" type="text/turtle" href="/drug/hydrocortisone.ttl" title="Turtle version of this document"/>
  <!--[if lt IE 9]>
  <script src="//cdn.nice.org.uk/V3.1/Scripts/html5shiv/html5shiv.js"></script>
  <![endif]-->
  
  <!-- Le styles -->
  <link href="//fonts.googleapis.com/css?family=Lato:300normal,300italic,400normal,400italic,700normal,700italic" rel="stylesheet"/>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.bootstrap.css" rel="stylesheet">
  <link rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css">
  
  <!--[if IE 7]>
  <link href="//cdn.nice.org.uk/V3.1/Content/NICE.glyphs-ie7.css" rel="stylesheet"/>
  <![endif]-->
  
  <meta content="#f6f6f6" name="msapplication-TileColor" />
  <meta content="//cdn.nice.org.uk/V3.1/Content/nice/favicon-144.png" name="msapplication-TileImage" />
  <link rel="shortcut icon" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon.ico" />
  <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3.1/Content/nice/favicon-152.png">
  
  <link href="/styles/style.css" rel="stylesheet" type="text/css" />
  <link href="/styles/bnf.css" rel="stylesheet" type="text/css" />
</head>
<body id="hydrocortisone" class="drug" data-publication="bnf" data-buildnumber="1.0.119-Live" data-release="live">
  
  
  <!-- Google Tag Manager -->
  <div id='gtmscript'></div>
  <noscript>
    <iframe src="//www.googletagmanager.com/ns.html?id=GTM-WF3WHX"
      height="0" width="0" style="display:none;visibility:hidden"></iframe>
  </noscript>
  <script>
    (function (w, d, s, l, i) {
      w[l] = w[l] || []; w[l].push({
        'gtm.start': new Date().getTime(), event: 'gtm.js'
      }); var f = d.getElementsByTagName(s)[0],
              j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
    })(window, document, 'script', 'dataLayer', 'GTM-WF3WHX');
  </script>
  <!-- End Google Tag Manager -->
  <div id="global-nav-header"></div>  <div class="container topic-container">
    
    <ul class="breadcrumb">
      <li><a href="../">Home</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li><a href="./">Drugs</a> <span class="divider icon-nice-chevron-right"></span></li>
      <li class="active"><span>HYDROCORTISONE</span></li>
    </ul>
  </div>
  
	<div class="container sticky-notice">
			<div id="site-distinction" class="bnf">
				<p>You are viewing BNF. If you require BNF for Children, use <a href="https://bnfc.nice.org.uk">BNFC.</a></p>
			</div>	</div>

  <div class="layout search-container hidden">
    <div id="search-results">
    </div>
  </div>
  <div class="layout">
    <h1 id=""><span>HYDROCORTISONE</span></h1>
  </div>


  <div class="layout layout-secondary-wide topic-container">

    <div class="content content-primary">
      <nav class="nav-toggle">
        <ul class="index unstyled nav-subtopics">
          <li>
            <a class="btn btn-transparent">
              <i class="pull-right icon-chevron-down"></i>
              <span>Show all parts of this monograph</span>
            </a>
          </li>
        </ul>
      </nav>

      <nav class="monograph-navigation">
        <ul class="index unstyled nav-subtopics grid2">
            <li><a href="#drugAction" class="scroll-to-href">Drug action</a></li>
            <li class="active"><a href="#indicationsAndDoses" class="scroll-to-href">Indications and dose</a></li>
            <li><a href="#unlicensedUse" class="scroll-to-href">Unlicensed use</a></li>
            <li><a href="#importantSafetyInformations" class="scroll-to-href">Important safety information</a></li>
            <li><a href="#contraIndications" class="scroll-to-href">Contra-indications</a></li>
            <li><a href="#cautions" class="scroll-to-href">Cautions</a></li>
          <li><a href="#interactions" class="scroll-to-href">Interactions</a></li>
            <li><a href="#sideEffects" class="scroll-to-href">Side-effects</a></li>
            <li><a href="#pregnancy" class="scroll-to-href">Pregnancy</a></li>
            <li><a href="#breastfeeding" class="scroll-to-href">Breast feeding</a></li>
            <li><a href="#hepaticImpairment" class="scroll-to-href">Hepatic impairment</a></li>
            <li><a href="#renalImpairment" class="scroll-to-href">Renal impairment</a></li>
            <li><a href="#monitoringRequirements" class="scroll-to-href">Monitoring requirements</a></li>
            <li><a href="#effectsOnLaboratoryTests" class="scroll-to-href">Effect on laboratory tests</a></li>
            <li><a href="#treatmentCessationInformation" class="scroll-to-href">Treatment cessation</a></li>
            <li><a href="#directionsForAdministration" class="scroll-to-href">Directions for administration</a></li>
            <li><a href="#prescribingAndDispensingInformations" class="scroll-to-href">Prescribing and dispensing information</a></li>
            <li><a href="#patientAndCarerAdvice" class="scroll-to-href">Patient and carer advice</a></li>
            <li><a href="#professionSpecificInformation" class="scroll-to-href">Profession specific information</a></li>
            <li><a href="#nationalFunding" class="scroll-to-href">National funding/access decisions</a></li>
            <li><a href="#lessSuitableForPrescribings" class="scroll-to-href">Less suitable for prescribing</a></li>
            <li><a href="#exceptionsToLegalCategory" class="scroll-to-href">Exceptions to legal category</a></li>
            <li><a href="#medicinalForms" class="scroll-to-href">Medicinal forms</a></li>
        </ul>
      </nav>

      <div id="monograph-content" class="">
        <section class="scroll-target" id="drugAction">
          <h2>Drug action</h2>
      
      
          <div class="prescribingInformation">
          <section class="prescribingInformationSection drugAction">
              <section class="advice DrugAction">
                <div>
                              <p>Hydrocortisone has equal glucocorticoid and mineralocorticoid activity. </p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="indicationsAndDoses">
          <h2>Indications and dose</h2>
      
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
          <section class="indicationsAndDose">
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Thyrotoxic crisis (thyroid storm)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>100&#8239;mg every 6&#8239;hours, to be administered as sodium succinate.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Adrenocortical insufficiency resulting from septic shock</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>50&#8239;mg every 6&#8239;hours, given in combination with fludrocortisone.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Acute hypersensitivity reactions such as angioedema of the upper respiratory tract and anaphylaxis (adjunct to adrenaline)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>100&#8211;300&#8239;mg, to be administered as sodium succinate.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Corticosteroid replacement, in patients who have taken more than 10&#8239;mg prednisolone daily (or equivalent) within 3 months of minor surgery under general anaesthesia</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection, or by intravenous infusion</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Initially 25&#8211;50&#8239;mg, to be administered at induction of surgery, the patient's usual oral corticosteroid dose is recommenced after surgery.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Corticosteroid replacement, in patients who have taken more than 10&#8239;mg prednisolone daily (or equivalent) within 3 months of moderate or major surgery</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">Initially by intravenous injection, or by intravenous infusion</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Initially 25&#8211;50&#8239;mg, to be administered at induction of surgery (following usual oral corticosteroid dose on the morning of surgery), followed by (by intravenous injection) 25&#8211;50&#8239;mg 3 times a day for 24 hours after moderate surgery and for 48&#8211;72 hours after major surgery.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Adrenocortical insufficiency in Addison&#8217;s disease or following adrenalectomy</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth using immediate-release medicines</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>20&#8211;30&#8239;mg daily in 2 divided doses, the larger dose to be given in the morning and the smaller in the evening, mimicking the normal diurnal rhythm of cortisol secretion, the optimum daily dose is determined on the basis of clinical response.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Adrenocortical insufficiency</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intramuscular injection, or by slow intravenous injection, or by intravenous infusion</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>100&#8211;500&#8239;mg 3&#8211;4 times a day or when required.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Severe inflammatory bowel disease</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By slow intravenous injection, or by intravenous infusion</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>100&#8211;500&#8239;mg 3&#8211;4 times a day or when required.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Replacement in adrenocortical insufficiency</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth using modified-release medicines</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>20&#8211;30&#8239;mg once daily, adjusted according to response, dose to be taken in the morning.</p>
                  </li>
                </ul>
              </div>
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By mouth using immediate-release medicines</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>20&#8211;30&#8239;mg daily in divided doses, adjusted according to response.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Ulcerative colitis</span></span>, <br/><span class="indication"><span class="indication">Proctitis</span></span>, <br/><span class="indication"><span class="indication">Proctosigmoiditis</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By rectum using rectal foam</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Initially 1&#8239;metered application 1&#8211;2 times a day for 2&#8211;3 weeks, then reduced to 1&#8239;metered application once daily on alternate days, to be inserted into the rectum.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Acute hypersensitivity reactions</span></span>, <br/><span class="indication"><span class="indication">Angioedema</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intramuscular injection, or by intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 1&#8211;5 months</span>
                    </span></strong><br/>
                    <p>Initially 25&#8239;mg 3 times a day, adjusted according to response.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 6 months&#8211;5 years</span>
                    </span></strong><br/>
                    <p>Initially 50&#8239;mg 3 times a day, adjusted according to response.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 6&#8211;11 years</span>
                    </span></strong><br/>
                    <p>Initially 100&#8239;mg 3 times a day, adjusted according to response.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>Initially 200&#8239;mg 3 times a day, adjusted according to response.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Mild inflammatory skin disorders such as eczemas</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">To the skin</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child</span>
                    </span></strong><br/>
                    <p>Apply 1&#8211;2 times a day, to be applied thinly.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Apply 1&#8211;2 times a day, to be applied thinly.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Nappy rash</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">To the skin</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child</span>
                    </span></strong><br/>
                    <p>Apply 1&#8211;2 times a day for no longer than 1 week, discontinued as soon as the inflammation subsides.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Severe acute asthma</span></span>, <br/><span class="indication"><span class="indication">Life-threatening acute asthma</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">By intravenous injection</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 1 month&#8211;1 year</span>
                    </span></strong><br/>
                    <p>4&#8239;mg/kg every 6&#8239;hours (max. per dose 100&#8239;mg), alternatively 25&#8239;mg every 6&#8239;hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 2&#8211;4 years</span>
                    </span></strong><br/>
                    <p>4&#8239;mg/kg every 6&#8239;hours (max. per dose 100&#8239;mg), alternatively 50&#8239;mg every 6&#8239;hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 5&#8211;11 years</span>
                    </span></strong><br/>
                    <p>4&#8239;mg/kg every 6&#8239;hours (max. per dose 100&#8239;mg), alternatively 100&#8239;mg every 6&#8239;hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>4&#8239;mg/kg every 6&#8239;hours (max. per dose 100&#8239;mg), alternatively 100&#8239;mg every 6&#8239;hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>100&#8239;mg every 6&#8239;hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Oral and perioral lesions</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">To the lesion using buccal tablet</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 1 month&#8211;11 years</span>
                    </span></strong><br/>
                    <p>Only on medical advice.</p>
                  </li>
                  <li class="dose child">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Child 12&#8211;17 years</span>
                    </span></strong><br/>
                    <p>1&#8239;lozenge 4 times a day, allowed to dissolve slowly in the mouth in contact with the ulcer.</p>
                  </li>
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>1&#8239;lozenge 4 times a day, allowed to dissolve slowly in the mouth in contact with the ulcer.</p>
                  </li>
                </ul>
              </div>
            </section>
            <section class="indicationAndDoseGroup">
              <h4 class="indications">
                <span class="indication"><span class="indication">Local treatment of conjunctival inflammation (short-term)</span></span><br/>
              </h4>
          
              <div class="dosage-group">
                <p class="specificity"><span class="routesOfAdministration">To the eye</span></p>
          
                <ul class="doses unstyled">
                  <li class="dose adult">
                    <strong class="patientGroupList">For <span class="patientGroup">
                        <span>Adult</span>
                    </span></strong><br/>
                    <p>Apply 2&#8239;drops 2&#8211;4 times a day for up to 14 days, to avoid relapse, frequency may be gradually reduced to once every other day.</p>
                  </li>
                </ul>
              </div>
            </section>
          </section>
          <section class="doseEquivalence">
            <h3>Dose equivalence and conversion</h3>
              <section class="advice DoseEquivalence,IndicationsAndDoseSection">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in adults</span></strong></p>
                <DIV>
                            
                            
                            <p>When switching from immediate-release hydrocortisone tablets to modified release <em>Plenadren</em><sup class="tm">&#174;</sup> use same total daily dose. Bioavailability of <em>Plenadren</em><sup class="tm">&#174;</sup> lower than immediate release tablets&#8212;monitor clinical response.</p>
                          </DIV>
              </section>
          </section>
          <section class="potency">
            <h3>Potency</h3>
              <section class="advice IndicationsAndDoseSection,Potency">
                <p class="specificity"><strong><span class="specificity">With <span class="route">topical</span> use</span></strong></p>
                <DIV>
                            
                            
                            <p>Hydrocortisone cream and ointment 0.5 to 2.5%: mild</p>
                          </DIV>
              </section>
          </section>
          </div>
      
            <h3>For <span>Hydrocortistab<sup class="tm">&#174;</sup></span></h3>
            <div id="hydrocortistab_indicationsAndDoses">
              <p><a href="/clinical-medicinal-product-information/hydrocortistab.html#indicationsAndDoses" data-action="load" data-target="#hydrocortistab_indicationsAndDoses" data-filter="#indicationsAndDoses .prescribingInformation">See <span>Hydrocortistab<sup class="tm">&#174;</sup></span></a></p>
            </div>
        </section>
      
        <section class="scroll-target" id="unlicensedUse">
          <h2>Unlicensed use</h2>
      
      
          <div class="prescribingInformation">
          <section class="unlicencedUse">
              <section class="advice UnlicencedUse">
                <p class="specificity"><strong><span class="specificity">With <span class="route">buccal</span> use in children</span></strong></p>
                <div>
                              
                              <p><em>Hydrocortisone mucoadhesive buccal tablets</em> licensed for use in children (under 12 years&#8212;on medical advice only).</p>
                            </div>
              </section>
              <section class="advice UnlicencedUse">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in children</span></strong></p>
                <div>
                              
                              <p>Use of injection by mouth is unlicensed.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="importantSafetyInformations">
          <h2>Important safety information</h2>
      
      
          <div class="prescribingInformation">
          <section class="importantSafetyInformation">
              <section class="advice ImportantSafetyInformation">
                <h4>MHRA/CHM advice: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration (August 2017)</h4>
                <div>
                              
                              <p>See <a href="/treatment-summary/corticosteroids-general-use.html">Corticosteroids, general use</a>.</p>
                            </div>
              </section>
              <section class="advice ImportantSafetyInformation">
                <h4>MHRA/CHM advice: Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks (December 2018)</h4>
                <p class="specificity"><strong><span class="specificity">In children</span></strong></p>
                <div>
                              
                              
                              <p>The MHRA has received reports of off-label use of hydrocortisone muco-adhesive buccal tablets for adrenal insufficiency in children.</p>
                              <p>Healthcare professionals are advised that:</p>
                              <ul>
                                <li>hydrocortisone muco-adhesive buccal tablets are indicated only for local use in the mouth for aphthous ulceration and should not be used to treat adrenal insufficiency;</li>
                                <li>substitution of licensed oral hydrocortisone formulations with muco-adhesive buccal tablets can result in insufficient cortisol absorption and, in stress situations, life-threatening adrenal crisis;</li>
                                <li>only hydrocortisone products licensed for adrenal replacement therapy should be used.</li>
                              </ul>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="contraIndications">
          <h2>Contra-indications</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_contraIndications">
              <p><a href="/drug-class/corticosteroids-systemic.html#contraIndications" data-action="load" data-target="#corticosteroids-systemic_contraIndications" data-filter="#contraIndications .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
            <h3>For all <span>CORTICOSTEROIDS (TOPICAL)</span></h3>
            <div id="corticosteroids-topical_contraIndications">
              <p><a href="/drug-class/corticosteroids-topical.html#contraIndications" data-action="load" data-target="#corticosteroids-topical_contraIndications" data-filter="#contraIndications .prescribingInformation">See <span>CORTICOSTEROIDS (TOPICAL)</span></a></p>
            </div>
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
          <section class="specificContraIndications">
            <div class="contraIndicationWithRoutes">
                <section class="advice ContraindicationsGroup,ContraindicationWithRoutes">
                  <p class="specificity"><strong><span class="specificity">With <span class="route">buccal</span> use</span></strong></p>
                  <p>
                                    <span class="contraindication">untreated local infection</span>
                                  </p>
                </section>
                <section class="advice ContraindicationsGroup,ContraindicationWithRoutes">
                  <p class="specificity"><strong><span class="specificity">With <span class="route">rectal</span> use</span></strong></p>
                  <p>
                  <span class="contraindication">abdominal or local infection</span>; <span class="contraindication">abscess</span>; <span class="contraindication">bowel perforation</span>; <span class="contraindication">extensive fistulas</span>; <span class="contraindication">intestinal obstruction</span>; <span class="contraindication">recent intestinal anastomoses</span></p>
                </section>
            </div>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="cautions">
          <h2>Cautions</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_cautions">
              <p><a href="/drug-class/corticosteroids-systemic.html#cautions" data-action="load" data-target="#corticosteroids-systemic_cautions" data-filter="#cautions .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
            <h3>For all <span>CORTICOSTEROIDS (TOPICAL)</span></h3>
            <div id="corticosteroids-topical_cautions">
              <p><a href="/drug-class/corticosteroids-topical.html#cautions" data-action="load" data-target="#corticosteroids-topical_cautions" data-filter="#cautions .prescribingInformation">See <span>CORTICOSTEROIDS (TOPICAL)</span></a></p>
            </div>
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
          <section class="specificCautions">
            <section class="cautionsWithRoutes">
                <section class="advice CautionsGroup,CautionsWithRoutes">
                  <p class="specificity"><strong><span class="specificity">When used by <span class="route">ear</span></span></strong></p>
                  <p>
                                    <span class="caution">avoid prolonged use</span>
                                  </p>
                </section>
                <section class="advice CautionsGroup,CautionsWithRoutes">
                  <p class="specificity"><strong><span class="specificity">With <span class="route">rectal</span> use</span></strong></p>
                  <p>
                                    <span class="caution">systemic absorption may occur</span>
                                  </p>
                </section>
            </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="interactions">
          <h2>Interactions</h2>
      
      
          <div class="prescribingInformation">
          <section class="interactionStatement">
              <section class="advice InteractionStatement">
                <h4>Route-specific information</h4>
                <div>
                              
                              <p>Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified.&#8239;However, as systemic absorption might occur with <strong>hydrocortisone</strong> <em>eye drops</em><strong>,</strong>&#8239;the possibility of interactions should be borne in mind.</p>
                            </div>
              </section>
          </section>
          </div>
      
          <div class="interactants">
            <h4>Individual interactants:</h4>
            <ul>
              <li><a href="/interaction/hydrocortisone-2.html" class="interactant"><span> Hydrocortisone </span></a></li>
            </ul>
          </div>
      
        </section>
      
        <section class="scroll-target" id="sideEffects">
          <h2>Side-effects</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_sideEffects">
              <p><a href="/drug-class/corticosteroids-systemic.html#sideEffects" data-action="load" data-target="#corticosteroids-systemic_sideEffects" data-filter="#sideEffects .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
            <h3>For all <span>CORTICOSTEROIDS (TOPICAL)</span></h3>
            <div id="corticosteroids-topical_sideEffects">
              <p><a href="/drug-class/corticosteroids-topical.html#sideEffects" data-action="load" data-target="#corticosteroids-topical_sideEffects" data-filter="#sideEffects .prescribingInformation">See <span>CORTICOSTEROIDS (TOPICAL)</span></a></p>
            </div>
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
          <section class="specificSideEffects">
            <section class="SideEffectsWithRoutes">
              <div class="notKnown">
                <h4>Frequency not known</h4>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="title">When used by eye (topical)</span></strong></p>
                    <p>
                                        <span class="sideEffect">eye stinging</span>
                                      </p>
                  </section>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="title">With intra-articular use</span></strong></p>
                    <p>
                                        <span class="sideEffect">myocardial rupture (<span class="sideEffectQualifier">following recent myocardial infarction</span>)</span>
                                      </p>
                  </section>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use</span></strong></p>
                    <p>
                    <span class="sideEffect">dyslipidaemia</span>; <span class="sideEffect">myocardial rupture (<span class="sideEffectQualifier">following recent myocardial infarction</span>)</span>; <span class="sideEffect">oedema</span></p>
                  </section>
                  <section class="advice SideEffectsGroup,SideEffectGroup,SideEffectsWithRoutes">
                    <p class="specificity"><strong><span class="title">With parenteral use</span></strong></p>
                    <p>
                    <span class="sideEffect">hiccups</span>; <span class="sideEffect">Kaposi's sarcoma</span>; <span class="sideEffect">lipomatosis</span>; <span class="sideEffect">myocardial rupture (<span class="sideEffectQualifier">following recent myocardial infarction</span>)</span></p>
                  </section>
              </div>
            </section>
          </section>
          </div>
      
        </section>
      
      
      
        <section class="scroll-target" id="pregnancy">
          <h2>Pregnancy</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_pregnancy">
              <p><a href="/drug-class/corticosteroids-systemic.html#pregnancy" data-action="load" data-target="#corticosteroids-systemic_pregnancy" data-filter="#pregnancy .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="breastfeeding">
          <h2>Breast feeding</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_breastfeeding">
              <p><a href="/drug-class/corticosteroids-systemic.html#breastfeeding" data-action="load" data-target="#corticosteroids-systemic_breastfeeding" data-filter="#breastfeeding .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="hepaticImpairment">
          <h2>Hepatic impairment</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_hepaticImpairment">
              <p><a href="/drug-class/corticosteroids-systemic.html#hepaticImpairment" data-action="load" data-target="#corticosteroids-systemic_hepaticImpairment" data-filter="#hepaticImpairment .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="renalImpairment">
          <h2>Renal impairment</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_renalImpairment">
              <p><a href="/drug-class/corticosteroids-systemic.html#renalImpairment" data-action="load" data-target="#corticosteroids-systemic_renalImpairment" data-filter="#renalImpairment .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="monitoringRequirements">
          <h2>Monitoring requirements</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_monitoringRequirements">
              <p><a href="/drug-class/corticosteroids-systemic.html#monitoringRequirements" data-action="load" data-target="#corticosteroids-systemic_monitoringRequirements" data-filter="#monitoringRequirements .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="effectsOnLaboratoryTests">
          <h2>Effect on laboratory tests</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_effectsOnLaboratoryTests">
              <p><a href="/drug-class/corticosteroids-systemic.html#effectsOnLaboratoryTests" data-action="load" data-target="#corticosteroids-systemic_effectsOnLaboratoryTests" data-filter="#effectsOnLaboratoryTests .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="treatmentCessationInformation">
          <h2>Treatment cessation</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_treatmentCessationInformation">
              <p><a href="/drug-class/corticosteroids-systemic.html#treatmentCessationInformation" data-action="load" data-target="#corticosteroids-systemic_treatmentCessationInformation" data-filter="#treatmentCessationInformation .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
      
          <div class="prescribingInformation">
          </div>
      
        </section>
      
        <section class="scroll-target" id="directionsForAdministration">
          <h2>Directions for administration</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (TOPICAL)</span></h3>
            <div id="corticosteroids-topical_directionsForAdministration">
              <p><a href="/drug-class/corticosteroids-topical.html#directionsForAdministration" data-action="load" data-target="#corticosteroids-topical_directionsForAdministration" data-filter="#directionsForAdministration .prescribingInformation">See <span>CORTICOSTEROIDS (TOPICAL)</span></a></p>
            </div>
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
          <section class="directionForAdministration">
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use in children</span></strong></p>
                <div>
                              
                              <p>For <em>intravenous administration</em>, dilute with Glucose 5% or Sodium Chloride 0.9%.</p>
                              <p>For <em>intermittent infusion</em> give over 20&#8211;30 minutes.</p>
                            </div>
              </section>
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in children</span></strong></p>
                <div>
                              
                              <p>For administration <em>by mouth</em>, injection solution may be swallowed [unlicensed use] but consider phosphate content.</p>
                              <p>For <em>Alkindi</em><sup class="tm">&#174;</sup>, manufacturer advises capsule should be opened and granules either administered directly into the mouth and then followed immediately with a drink, or sprinkled onto a spoonful of soft food (such as yoghurt) and given immediately. Granules should not be chewed or added to liquid before administration due to the bitter taste, and they should not be given via a nasogastric tube.</p>
                            </div>
              </section>
              <section class="advice DirectionForAdministration">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use in adults</span></strong></p>
                <div>
                              
                              <p>For <em>intravenous infusion</em> (<em>SoluCortef</em><sup class="tm">&#174;</sup>), give continuously <em>or</em> intermittently <em>or via</em> drip tubing <em>in</em> Glucose 5% <em>or</em> Sodium chloride 0.9%.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="prescribingAndDispensingInformations">
          <h2>Prescribing and dispensing information</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (TOPICAL)</span></h3>
            <div id="corticosteroids-topical_prescribingAndDispensingInformations">
              <p><a href="/drug-class/corticosteroids-topical.html#prescribingAndDispensingInformations" data-action="load" data-target="#corticosteroids-topical_prescribingAndDispensingInformations" data-filter="#prescribingAndDispensingInformations .prescribingInformation">See <span>CORTICOSTEROIDS (TOPICAL)</span></a></p>
            </div>
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
          <section class="prescribingAndDispensingInformation">
              <section class="advice PrescribingAndDispensingInformation">
                <p class="specificity"><strong><span class="specificity">With <span class="route">topical</span> use</span></strong></p>
                <div>
                              
                              <p>When hydrocortisone cream or ointment is prescribed and no strength is stated, the 1% strength should be supplied.</p>
                              <p>Although <em>Dioderm</em><sup class="tm">&#174;</sup> contains only 0.1% hydrocortisone, the formulation is designed to provide a clinical activity comparable to that of Hydrocortisone Cream 1% BP.</p>
                            </div>
              </section>
              <section class="advice PrescribingAndDispensingInformation">
                <p class="specificity"><strong><span class="specificity">In children</span></strong></p>
                <div>
                              
                              <p>The RCPCH and NPPG recommend that, when a liquid special of hydrocortisone is required, the following strength is used: 5&#8239;mg/5&#8239;mL.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
      
        <section class="scroll-target" id="patientAndCarerAdvice">
          <h2>Patient and carer advice</h2>
      
            <h3>For all <span>CORTICOSTEROIDS (SYSTEMIC)</span></h3>
            <div id="corticosteroids-systemic_patientAndCarerAdvice">
              <p><a href="/drug-class/corticosteroids-systemic.html#patientAndCarerAdvice" data-action="load" data-target="#corticosteroids-systemic_patientAndCarerAdvice" data-filter="#patientAndCarerAdvice .prescribingInformation">See <span>CORTICOSTEROIDS (SYSTEMIC)</span></a></p>
            </div>
            <h3>For all <span>CORTICOSTEROIDS (TOPICAL)</span></h3>
            <div id="corticosteroids-topical_patientAndCarerAdvice">
              <p><a href="/drug-class/corticosteroids-topical.html#patientAndCarerAdvice" data-action="load" data-target="#corticosteroids-topical_patientAndCarerAdvice" data-filter="#patientAndCarerAdvice .prescribingInformation">See <span>CORTICOSTEROIDS (TOPICAL)</span></a></p>
            </div>
      
          <h3>For <span>HYDROCORTISONE</span></h3>
          <div class="prescribingInformation">
              <section class="generalPatientAdvice">
              			<section class="advice GeneralPatientAdvice,PatientAndCarerAdvice">
              			  <p class="specificity"><strong><span class="specificity">With <span class="route">systemic</span> use</span></strong></p>
              			  <div>
              			                
              			                <p>Patient counselling is advised for hydrocortisone tablets and injections (steroid card).</p>
              			              </div>
              			</section>
              			<section class="advice GeneralPatientAdvice,PatientAndCarerAdvice">
              			  <p class="specificity"><strong><span class="specificity">With <span class="route">topical</span> use</span></strong></p>
              			  <div>
              			                
              			                <p>Patient counselling is advised for hydrocortisone cream and ointment (application).</p>
              			              </div>
              			</section>
              </section>
          </div>
        </section>
      
        <section class="scroll-target" id="professionSpecificInformation">
          <h2>Profession specific information</h2>
      
      
          <div class="prescribingInformation">
          <div class="dentalPractitionersFormularyInformation">
            <h3>Dental practitioners' formulary</h3>
              <section class="advice DentalPractitionersFormularyInformation">
                <p class="specificity"><strong><span class="specificity">With <span class="route">buccal</span> use</span></strong></p>
                <div>
                              
                              <p>Mucoadhesive buccal tablets may be prescribed as Hydrocortisone Oromucosal Tablets.</p>
                            </div>
              </section>
              <section class="advice DentalPractitionersFormularyInformation">
                <p class="specificity"><strong><span class="specificity">With <span class="route">topical</span> use</span></strong></p>
                <div>
                              
                              <p>Hydrocortisone Cream 1% 15&#8239;g may be prescribed.</p>
                            </div>
              </section>
          </div>
          </div>
      
        </section>
      
        <section class="scroll-target" id="nationalFunding">
          <h2>National funding/access decisions</h2>
      
      
          <div class="prescribingInformation">
          <section class="smcDecision">
            <h3>Scottish Medicines Consortium (SMC) Decisions</h3>
              <section class="advice FundingDecision,SmcDecisions">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in adults</span></strong></p>
                <div class="smcDecision">
                                <p class="fundingIdentifier">SMC No. 848/12</p>
                                <a href="https://www.scottishmedicines.org.uk/medicines-advice/hydrocortisone-plenadren-fullsubmission-84812/">www.scottishmedicines.org.uk/medicines-advice/hydrocortisone-plenadren-fullsubmission-84812/</a>
                                <div>
                                  
                                  <p>The <em>Scottish Medicines Consortium</em> has advised (December 2016) that hydrocortisone modified release (<em>Plenadren</em><sup class="tm">&#174;</sup>) is <strong>not</strong> recommended for use within NHS Scotland for treatment of adrenal insufficiency in adults as there was insufficient evidence submitted.</p>
                                </div>
                              </div>
              </section>
              <section class="advice FundingDecision,SmcDecisions">
                <p class="specificity"><strong><span class="specificity">With <span class="route">oral</span> use in children</span></strong></p>
                <div class="smcDecision">
                                <p class="fundingIdentifier">SMC No. SMC2088</p>
                                <a href="https://www.scottishmedicines.org.uk/medicines-advice/hydrocortisone-alkindi-fullsub-smc2088/">www.scottishmedicines.org.uk/medicines-advice/hydrocortisone-alkindi-fullsub-smc2088/</a>
                                <div>
                                  
                                  <p>The <em>Scottish Medicines Consortium</em> (October 2018) has advised that hydrocortisone (<em>Alkindi</em><sup class="tm">&#174;</sup>) is accepted for restricted use within NHS Scotland for the first-line treatment of patients with adrenal insufficiency aged from birth to less than six years of age for whom hydrocortisone must otherwise be individually prepared by manipulation such as by compounding (or crushing) or by production of special solutions in order to produce age-appropriate doses, or hydrocortisone given as off-label buccal tablets.</p>
                                  <p>This advice is contingent upon the continuing availability of the patient access scheme in NHS Scotland or a list price that is equivalent or lower.</p>
                                </div>
                              </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="lessSuitableForPrescribings">
          <h2>Less suitable for prescribing</h2>
      
      
          <div class="prescribingInformation">
          <section class="lessSuitableForPrescribing">
              <section class="advice LessSuitableForPrescribing">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intravenous</span> use</span></strong></p>
                <div>
                              
                              <p>Hydrocortisone as the sodium phosphate is less suitable for prescribing as paraesthesia and pain (particularly in the perineal region) may follow intravenous injection.</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="exceptionsToLegalCategory">
          <h2>Exceptions to legal category</h2>
      
      
          <div class="prescribingInformation">
          <section class="exceptionToLegalCategory">
              <section class="advice ExceptionToLegalCategory">
                <p class="specificity"><strong><span class="specificity">With <span class="route">intramuscular</span> use or <span class="route">intravenous</span> use</span></strong></p>
                <div>
                              
                              <p>Prescription only medicine restriction does not apply where administration is for saving life in emergency.</p>
                            </div>
              </section>
              <section class="advice ExceptionToLegalCategory">
                <h4>Over-the-counter hydrocortisone preparations</h4>
                <p class="specificity"><strong><span class="specificity">With <span class="route">topical</span> use</span></strong></p>
                <div>
                              
                              
                              <p>Skin creams and ointments containing hydrocortisone (alone or with other ingredients) can be sold to the public for the treatment of allergic contact dermatitis, irritant dermatitis, insect bite reactions and mild to moderate eczema in patients over 10 years, to be applied sparingly over the affected area 1&#8211;2 times daily for max. 1 week. Over-the-counter hydrocortisone preparations should not be sold without medical advice for children under 10 years or for pregnant women; they should <strong>not</strong> be sold for application to the face, anogenital region, broken or infected skin (including cold sores, acne, and athlete&#8217;s foot).</p>
                            </div>
              </section>
          </section>
          </div>
      
        </section>
      
        <section class="scroll-target" id="medicinalForms">
          <h2>Medicinal forms</h2>
      
          <section class="licensingVariationStatement">
            <p>There can be variation in the licensing of different medicines containing the same drug.</p>
          </section>
      
            <section class="availableFormsStatement">
              <p>Forms available from special-order manufacturers include: capsule, oral suspension, oral solution, liquid, cream, ointment</p>
            </section>
      
          <section class="medicinalForms">
            <p><a href="../medicinal-forms/hydrocortisone.html"><span>Tablet</span>,  <span>Soluble tablet</span>,  <span>Muco-adhesive buccal tablet</span>,  <span>Modified-release tablet</span>,  <span>Solution for injection</span>,  <span>Powder for solution for injection</span>,  <span>Powder and solvent for solution for injection</span>,  <span>Suspension for injection</span>,  <span>Eye drops</span>,  <span>Cream</span>,  <span>Ointment</span> </a></p>
          </section>
        </section>
      </div>

      
      <div class="back-to-top-container">
        <a class="btn btn-default back-to-top">
        	<span class="hidden-xs">Back to top</span>
        	<span class="icon-chevron-up" style="padding: 0px 4px;"></span>
      	</a>
      </div>    </div>

    <div class="content content-secondary">

        <section class="related-links scroll-target related-treatment-summary" id="related-treatment-summary">
          <h4>Related Treatment Summaries</h4>
          <ul class="">
            <li>
              <a href="../treatment-summary/antihistamines-allergen-immunotherapy-and-allergic-emergencies.html" class="related-link"><span>Antihistamines, allergen immunotherapy and allergic emergencies</span></a>
            </li>
            <li>
              <a href="../treatment-summary/antithyroid-drugs.html" class="related-link"><span>Antithyroid drugs</span></a>
            </li>
            <li>
              <a href="../treatment-summary/asthma-acute.html" class="related-link"><span>Asthma, acute</span></a>
            </li>
            <li>
              <a href="../treatment-summary/corticosteroids-general-use.html" class="related-link"><span>Corticosteroids, general use</span></a>
            </li>
            <li>
              <a href="../treatment-summary/corticosteroids-inflammatory-disorders.html" class="related-link"><span>Corticosteroids, inflammatory disorders</span></a>
            </li>
            <li>
              <a href="../treatment-summary/corticosteroids-replacement-therapy.html" class="related-link"><span>Corticosteroids, replacement therapy </span></a>
            </li>
            <li>
              <a href="../treatment-summary/crohns-disease.html" class="related-link"><span>Crohn's disease</span></a>
            </li>
            <li>
              <a href="../treatment-summary/emollient-and-barrier-preparations.html" class="related-link"><span>Emollient and barrier preparations</span></a>
            </li>
            <li>
              <a href="../treatment-summary/glucocorticoid-therapy.html" class="related-link"><span>Glucocorticoid therapy</span></a>
            </li>
            <li>
              <a href="../treatment-summary/medical-emergencies-in-the-community.html" class="related-link"><span>Medical emergencies in the community</span></a>
            </li>
            <li>
              <a href="../treatment-summary/oral-ulceration-and-inflammation.html" class="related-link"><span>Oral ulceration and inflammation</span></a>
            </li>
            <li>
              <a href="../treatment-summary/pneumocystis-pneumonia.html" class="related-link"><span>Pneumocystis pneumonia</span></a>
            </li>
            <li>
              <a href="../treatment-summary/skin-infections.html" class="related-link"><span>Skin infections</span></a>
            </li>
            <li>
              <a href="../treatment-summary/soft-tissue-disorders.html" class="related-link"><span>Soft-tissue disorders</span></a>
            </li>
            <li>
              <a href="../treatment-summary/thyroid-hormones.html" class="related-link"><span>Thyroid hormones</span></a>
            </li>
            <li>
              <a href="../treatment-summary/topical-corticosteroids.html" class="related-link"><span>Topical corticosteroids</span></a>
            </li>
            <li>
              <a href="../treatment-summary/ulcerative-colitis.html" class="related-link"><span>Ulcerative colitis</span></a>
            </li>
          </ul>
        </section>

        <section class="classifications scroll-target primary-classifications" id="primary-classifications">
          <div id="primary">
            <p>Other drugs classified as <a href="/drug-classification/primary/hydrocortisone.html" data-target="#primary" data-action="load" class="classification primary-classification">corticosteroids</a></p>
          </div>
        </section>

      

    </div>
  </div>

  
  <div id="global-nav-footer"></div>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/jquery/jquery-1.10.2.min.js"></script>
  
  
   
  <!-- Bootstrap  -->
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/twitter.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/NICE.bootstrap.min.js"></script>
  <script src="https://cdn.nice.org.uk/V3.1/Scripts/nice/NICE.EventTracking.js"></script>
  
  <script src="/scripts/remoteload.js"></script>
  <script src="/scripts/NICE.scrollspy.js"></script>
  <script src="/scripts/NICE.asyoutype.js"></script>
  <script src="/scripts/stickyfill.min.js"></script>
  <script src="/scripts/NICE.bnf.js"></script>
    <script>
  	    (function( $ ) {
  	      $(function() {
  	        var $backToTop = $( '#backToTop' );
  	        var $win = $( window );
  	        var opt = { min: 500, fadeSpeed: 100, scrollSpeed: 300 };
  	  
  	        $( document.body ).on('click', '#backToTop', function( ev ) {
  	          ev.preventDefault();
  	  
  	          $( "html, body" ).animate({ scrollTop: 0 }, opt.scrollSpeed );
  	        });
  	  
  	        $win.on('scroll', function() {
  	          $backToTop[ 'fade' + ( $win.scrollTop() >= opt.min ? 'In' : 'Out' ) ]( opt.fadeSpeed );
  	        });
  	      });
  	    })( jQuery );
  	  </script>
  	  	<script> 
  				var queryMatch = window.location.hash.match("q=([^&]+)");
  				var searchPlaceHolder = "Search BNFâ¦";
  				var global_nav_config = {
  				service: "bnf",
  				header: {
  					skipLinkId: "content-start",
  					cookie: true,
  					auth: {
  						environment: "live" == "live" ? "live" : "beta",
  						provider: "niceAccounts"
  					},
  					search: {
  						url: "/search?q=",
  						query: queryMatch ? decodeURIComponent(queryMatch[1]) : "",
  						autocomplete: "/typeahead?ajax=ajax",
  						placeholder: searchPlaceHolder,
  						onSearching: function(e) {
  								window.location.href = "#Search?q=" + encodeURIComponent(e.query);
  						}
  					},
  					onRendered: "globalNavRendered"
  				}
  	  	};
  	  </script>
  	  
  			<!--[if lt IE 9]>
  					<script src="//cdn.nice.org.uk/global-nav/global-nav.ie8.min.js"></script>
  			<![endif]-->
  			<script src="//cdn.nice.org.uk/global-nav/global-nav.min.js"></script>
  	
  	  
  
  
  
  <!-- Test for touch device -->
  <script type="text/javascript">
    $('body').addClass('ontouchstart' in document.documentElement ? 'touch-screen-device' : 'non-touch-screen-device');
  </script>
  
  <!-- TODO: What is this doing? -->
  <script type="text/javascript">
    $(document).ajaxSend(function (event, jqxhr, settings) { settings.url = settings.url + (~settings.url.indexOf("?") ? "&" : "?")+ "ajax=ajax"; });
  </script></body>
</html>
